HighVista Strategies’s Alpine Immune Sciences Inc ALPN Stock Holding History

HighVista Strategies’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,783	Closed	-$903K	–	163
2024 Q1	$903K	Sell	22,783 -17,078	-43%	-$504K	0.32%	99
2023 Q4	$760K	Hold	39,861	–	–	0.28%	104
2023 Q3	$456K	Sell	39,861 -50,426	-56%	-$621K	0.21%	118
2023 Q2	$928K	Hold	90,287	–	–	0.42%	53
2023 Q1	$697K	Buy	+90,287	New	+$719K	0.57%	61
2021 Q4	–	Sell	-14,268	Closed	-$152K	–	130
2021 Q3	$152K	Buy	+14,268	New	+$131K	0.1%	75

HighVista Strategies's ALPN Position: Q2 2024 in Review

HighVista Strategies sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 22,783 shares — an estimated $903K sold.

HighVista Strategies first reported a position in ALPN in Q3 2021 and held it in 6 quarters. The position peaked at $928K in Q2 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

HighVista Strategies reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
HighVista Strategies sold 22,783 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $903K.
HighVista Strategies first reported a position in Alpine Immune Sciences Inc in Q3 2021 and held it in 6 quarters.
HighVista Strategies's Alpine Immune Sciences Inc position peaked at $928K in Q2 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on HighVista Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.